bioRxiv Science⌕ Search

Biology subjects

Duong, L. T.

Publications and source records attributed to Duong, L. T..

2 recordsLinked to original sources

The Reward Positivity Does Not Encode Current Reward Value

Successful behavioral adaptation requires an ongoing assessment of rewarding outcomes based on ones current state. A frontocentral ERP associated with reward feedback, the reward positivity (RewP), has been linked to reflect information about reward value and motivational states. It is, however, unclear if changes in the RewP are influenced by changes in reward value as a function of motivational state. To examine this, hungry participants (n=31) completed two rounds of a modified Doors Task incorporating Pavlovian conditioning during EEG recordings and obtained feedback associated with sweet and savory food reinforcers equally matched in pleasantness and desirability. Participants underwent reinforcer devaluation, a paradigm designed to isolate inference-based behavior based on decreasing reward value, in between rounds by eating one of the foods to satiety. Prior to devaluation, participants were hungry and rated both food reinforcers equally pleasant. After devaluation, participants were sated and rated the devalued food, but not the non-devalued food, significantly less pleasant, suggesting a sensory-specific change in reward value. Logistic regression of win-stay/lose-switch behavior during the Doors Task shows participants made sensory-specific adjustments in food preferences during post-devaluation. Non-parametric permutation tests based on the tmax statistic performed revealed no significant differences in RewP amplitudes, suggesting the RewP is insensitive to reinforcer devaluation. This could not be explained by differences in perceived pleasantness or desirability. These findings suggest that affective and motivational factors such as tracking inferences based on decreases in reward value did not modulate the RewP.

neuroscience↗

Effects of Parathyroid Hormone, Alendronate and Odanacatib on the mineralisation process in intracortical and endocortical Haversian boneof ovariectomized rabbits

Although cortical bone strength depends on optimal bone composition, the influences of standard therapeutic agents for osteoporosis on bone mineral accrual in cortical bone are not understood. This study compared effects on cortical bone composition of two current therapeutic approaches for osteoporosis: the anti-resorptive bisphosphonate alendronate (ALN), and anabolic intermittent parathyroid hormone (PTH). The experimental anti-resorptive cathepsin K inhibitor, odanacatib (ODN) which inhibits resorption without inhibiting bone formation, was also tested.\n\nTo determine effects of these agents on Haversian remodeling and mineral accrual, we compared ALN (100g/kg/2xweek), PTH(1-34) (15g/kg, 5x/week) and ODN (7.5M/day) administered for 10 months commencing 6 months after ovariectomy (OVX) in skeletally mature rabbits by histomorphometry. We used synchrotron-based Fourier-transform infrared microspectroscopy (sFTIRM), coupled to fluorochrome labelling, to measure maturation of the cortical matrix in situ at both endocortical and intracortical sites of bone formation.\n\nPTH and ODN, but not ALN, treatment increased bone toughness, and PTH treatment stimulated bone formation, not only on endocortical and periosteal bone, but also in intracortical pores. In Sham and OVX rabbits, normal matrix maturation was observed at both endocortical and intracortical sites including: mineral accrual (increasing mineral:matrix), carbonate substitution (carbonate:mineral) and collagen molecular compaction (amide I:II) in situ in endocortical and intracortical bone. ALN treatment reduced bone formation on these surfaces. In ALN-treated bone, while intracortical bone matured normally, endocortical bone did not show a significant increase in mineral:matrix. ODN treatment resulted in slower mineral accrual and limited carbonate substitution. While PTH-treatment did not modify matrix maturation in endocortical bone, the initial stages of mineral accrual were slower in intracortical bone.\n\nIn conclusion, these three classes of therapy have differing effects on both bone formation, and the process of bone matrix maturation. ALN suppresses bone formation, and the normal process of matrix maturation in endocortical bone. ODN does not suppress bone formation, but limits mineral accrual. PTH stimulates bone formation, and the matrix formed matures normally in endocortical bone. The ability of PTH treatment to stimulate bone formation in intracortical bone may provide a novel additional mechanism by which PTH increases bone strength.

cell biology↗